Identification of critical amino acid residues on human dihydrofolate reductase protein that mediate RNA recognition

被引:27
作者
Tai, NW
Ding, YY
Schmitz, JC
Chu, E
机构
[1] Yale Univ, Sch Med, Yale Canc Ctr, Dept Med & Pharmacol, New Haven, CT 06520 USA
[2] VA Connecticut Healthcare Syst, New Haven, CT 06520 USA
关键词
D O I
10.1093/nar/gkf562
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies have shown that human dihydrofolate reductase (DHFR) acts as an RNA-binding protein, in which it binds to its own mRNA and, in so doing, results in translational repression. In this study, we used RNA gel mobility shift and nitrocellulose filter-binding assays to further investigate the specificity of the interaction between human DHFR protein and human DHFR mRNA. Site-directed mutagenesis was used to identify the critical amino acid residues on DHFR protein required for RNA recognition. Human His-Tag DHFR protein specifically binds to human DHFR mRNA, while unrelated proteins including thymidylate synthase, p53 and glutathione-S-transferase were unable to form a ribonucleoprotein complex with DHFR mRNA. The Cys6 residue is essential for RNA recognition, as mutation at this amino acid with either an alanine (C6A) or serine (C6S) residue almost completely abrogated RNA-binding activity. Neither one of the cysteine mutant proteins was able to repress the in vitro translation of human DHFR mRNA. Mutations at amino acids Ile7, Arg28 and Phe34, significantly reduced RNA-binding activity. An RNA footprinting analysis identified three different RNA sequences, bound to DHFR protein, ranging in size from 16 to 45 nt, while a UV cross-linking analysis isolated an similar to16 nt RNA sequence bound to DHFR. These studies begin to identify the critical amino acid residues on human DHFR that mediate RNA binding either through forming direct contact points with RNA or through maintaining the protein in an optimal structure that allows for the critical RNA-binding domain to be accessible.
引用
收藏
页码:4481 / 4488
页数:8
相关论文
共 34 条
[1]  
Albor A, 1998, CANCER RES, V58, P2091
[2]   THE INTRACELLULAR CONTENT OF DIHYDROFOLATE-REDUCTASE - POSSIBILITIES FOR CONTROL AND IMPLICATIONS FOR CHEMOTHERAPY [J].
BASTOW, KF ;
PRABHU, R ;
CHENG, YC .
ADVANCES IN ENZYME REGULATION, 1984, 22 :15-26
[3]   DISMUTATION OF DIHYDROFOLATE BY DIHYDROFOLATE-REDUCTASE [J].
BLAKLEY, RL ;
COCCO, L .
BIOCHEMISTRY, 1984, 23 (11) :2377-2383
[4]   INTERACTION OF R17 COAT PROTEIN WITH SYNTHETIC VARIANTS OF ITS RIBONUCLEIC-ACID BINDING-SITE [J].
CAREY, J ;
LOWARY, PT ;
UHLENBECK, OC .
BIOCHEMISTRY, 1983, 22 (20) :4723-4730
[5]   SPECIFIC BINDING OF HUMAN DIHYDROFOLATE-REDUCTASE PROTEIN TO DIHYDROFOLATE-REDUCTASE MESSENGER-RNA INVITRO [J].
CHU, E ;
TAKIMOTO, CH ;
VOELLER, D ;
GREM, JL ;
ALLEGRA, CJ .
BIOCHEMISTRY, 1993, 32 (18) :4756-4760
[6]   IDENTIFICATION OF AN RNA-BINDING SITE FOR HUMAN THYMIDYLATE SYNTHASE [J].
CHU, E ;
VOELLER, D ;
KOELLER, DM ;
DRAKE, JC ;
TAKIMOTO, CH ;
MALEY, GF ;
MALEY, F ;
ALLEGRA, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :517-521
[7]   AUTOREGULATION OF HUMAN THYMIDYLATE SYNTHASE MESSENGER-RNA TRANSLATION BY THYMIDYLATE SYNTHASE [J].
CHU, E ;
KOELLER, DM ;
CASEY, JL ;
DRAKE, JC ;
CHABNER, BA ;
ELWOOD, PC ;
ZINN, S ;
ALLEGRA, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :8977-8981
[8]  
CHU E, 1996, CANC CHEMOTHERAPY PR, P110
[9]  
COWAN KH, 1986, MOL PHARMACOL, V30, P69
[10]   PURIFICATION AND CHARACTERIZATION OF DIHYDROFOLATE-REDUCTASE FROM METHOTREXATE-RESISTANT HUMAN-LYMPHOBLASTOID CELLS [J].
DELCAMP, TJ ;
SUSTEN, SS ;
BLANKENSHIP, DT ;
FREISHEIM, JH .
BIOCHEMISTRY, 1983, 22 (03) :633-639